Health X Platform Schedules Board Meeting to Approve Q2 FY27 Financial Results
Sastasundar Ventures Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Health X Platform Schedules Board Meeting to Approve Q2 FY27 Financial Results Health X Platform Limited (formerly Sastasundar Ventures Limited) has scheduled a Board of Directors meeting on 14th Nov'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Additionally, the company's trading window for dealing in its securities will remain closed until 48 hours following the formal declaration and submission of the financial results to the stock exchanges.
Original exchange filing (PDF)
More announcements from Sastasundar Ventures Ltd
- Disclosure under Listing Regulations - Submission of Audio recording of the Earnings Conference call for Q2 FY27 路 17 Nov 2026
- Please find attached the Investor Presentation. 路 14 Nov 2026
- Please find attached the unaudited financial results for the quarter and half year ended 30th September, 2026 路 14 Nov 2026
- Please find attached the Outcome of Board meeting held on 14th November, 2026 路 14 Nov 2026
- Intimation of Schedule of the Earnings Conference Call for Q2 of FY2026-27 and registration Link thereof 路 16 Nov 2026
- To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on 30th September, 2026 路 14 Nov 2026
- HEALTH X PLATFORM LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . 路 14 Nov 2026
- Disclosure of Voting Results of the 37th AGM of the Company held on Monday, 28th September, 2026 路 29 Sept 2026
